片仔癀PZH2107Ⅱ期临床试验完成首例受试者入组

Group 1 - The core point of the article is that Pianzaihuang (片仔癀) has announced a collaboration with Shanghai Lidao Pharmaceutical Technology Co., Ltd. to develop the project PZH2107, which has entered Phase II clinical trials for treating fibromyalgia [1] - The first subject has been enrolled in the randomized, double-blind, placebo-controlled, multi-center Phase II clinical trial for PZH2107 [1] - As of the announcement date, there are no approved drugs with the same target and indication as PZH2107 listed on the National Medical Products Administration's website [1]